LLY

907.17

-2.58%↓

JNJ

186.78

+0.33%↑

UNH

316.99

-2.22%↓

NVS

126.22

-0.15%↓

ABT

125.37

+0.7%↑

LLY

907.17

-2.58%↓

JNJ

186.78

+0.33%↑

UNH

316.99

-2.22%↓

NVS

126.22

-0.15%↓

ABT

125.37

+0.7%↑

LLY

907.17

-2.58%↓

JNJ

186.78

+0.33%↑

UNH

316.99

-2.22%↓

NVS

126.22

-0.15%↓

ABT

125.37

+0.7%↑

LLY

907.17

-2.58%↓

JNJ

186.78

+0.33%↑

UNH

316.99

-2.22%↓

NVS

126.22

-0.15%↓

ABT

125.37

+0.7%↑

LLY

907.17

-2.58%↓

JNJ

186.78

+0.33%↑

UNH

316.99

-2.22%↓

NVS

126.22

-0.15%↓

ABT

125.37

+0.7%↑

Search

Kala Pharmaceuticals Inc

Abierto

0.7 -2.78

Resumen

Variación precio

24h

Actual

Mínimo

0.62

Máximo

0.76

Métricas clave

By Trading Economics

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+985.53% upside

Dividendos

By Dow Jones

Próximas Ganancias

10 nov 2025

Kala Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 nov 2025, 23:38 UTC

Ganancias

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 nov 2025, 23:00 UTC

Ganancias

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 nov 2025, 22:19 UTC

Ganancias
Principales Movimientos del Mercado

Block Shares Slide After 3Q Results Miss Estimates

6 nov 2025, 21:53 UTC

Ganancias

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 nov 2025, 23:45 UTC

Ganancias

Wheaton Precious Metals 3Q Sales $476M >WPM

6 nov 2025, 23:45 UTC

Ganancias

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 nov 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 nov 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Fall After U.S. Tech Stocks Drop

6 nov 2025, 23:45 UTC

Ganancias

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 nov 2025, 23:38 UTC

Charlas de Mercado

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 nov 2025, 23:15 UTC

Ganancias

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 nov 2025, 23:14 UTC

Ganancias

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 nov 2025, 23:14 UTC

Ganancias

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 nov 2025, 23:13 UTC

Ganancias

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 nov 2025, 23:08 UTC

Ganancias

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 nov 2025, 23:08 UTC

Ganancias

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 nov 2025, 23:07 UTC

Ganancias

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 nov 2025, 23:07 UTC

Ganancias

Suzano 3Q Rev BRL12.2B >SUZ

6 nov 2025, 22:47 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 nov 2025, 22:47 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 nov 2025, 22:45 UTC

Adquisiciones, fusiones, absorciones

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 nov 2025, 22:25 UTC

Adquisiciones, fusiones, absorciones

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 nov 2025, 22:13 UTC

Ganancias

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 nov 2025, 22:02 UTC

Ganancias

Century Aluminum 3Q Sales $632.2M >CENX

6 nov 2025, 22:02 UTC

Ganancias

Century Aluminum 3Q Adj EPS 56c >CENX

6 nov 2025, 21:53 UTC

Ganancias

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 nov 2025, 21:51 UTC

Adquisiciones, fusiones, absorciones

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 nov 2025, 21:50 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

6 nov 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Kala Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

985.53% repunte

Estimación a 12 Meses

Media 8.25 USD  985.53%

Máximo 15 USD

Mínimo 1.5 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Kala Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

1

Comprar

2

Mantener

0

Vender

Finanzas

$

Acerca de Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat